Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Contineum Therapeutics (CTNM) Shares Outstanding (Diluted Average) (2024)

Contineum Therapeutics (CTNM) has 1 years of Shares Outstanding (Diluted Average) data on record, last reported at $19.4 million in Q4 2024.

  • For Q4 2024, Shares Outstanding (Diluted Average) changed N/A year-over-year to $19.4 million; the TTM value through Dec 2024 reached $19.4 million, changed N/A, while the annual FY2024 figure was $19.4 million, N/A changed from the prior year.
  • Shares Outstanding (Diluted Average) reached $19.4 million in Q4 2024 per CTNM's latest filing.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $19.4 million in Q4 2024 and bottomed at $19.4 million in Q4 2024.